Zimmer Biomet entered into a global license agreement with Bactiguard, an infection prevention technology company based in Sweden.
Three things to know:
1. Zimmer Biomet will apply Bactiguard's infection prevention technology to its orthopedic trauma implants.
2. The agreement entails a $3 million upfront license fee, with an additional $2 million contingent upon U.S. regulatory clearance and net sales after commercialization.
3. The use of Bactiguard's infection prevention technology on orthopedic trauma implants was CE marked in December 2018.
More articles on devices:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights